Laura Mataseje

1.6k total citations
44 papers, 972 citations indexed

About

Laura Mataseje is a scholar working on Molecular Medicine, Endocrinology and Clinical Biochemistry. According to data from OpenAlex, Laura Mataseje has authored 44 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Medicine, 24 papers in Endocrinology and 14 papers in Clinical Biochemistry. Recurrent topics in Laura Mataseje's work include Antibiotic Resistance in Bacteria (41 papers), Bacterial Identification and Susceptibility Testing (14 papers) and Enterobacteriaceae and Cronobacter Research (13 papers). Laura Mataseje is often cited by papers focused on Antibiotic Resistance in Bacteria (41 papers), Bacterial Identification and Susceptibility Testing (14 papers) and Enterobacteriaceae and Cronobacter Research (13 papers). Laura Mataseje collaborates with scholars based in Canada, South Africa and United States. Laura Mataseje's co-authors include Michael R. Mulvey, David A. Boyd, M. R. Mulvey, George G. Zhanel, Cindi R. Corbett, Patricia J. Baudry, Kym Antonation, Lisa Schmidt, Andrea D. Tyler and Daryl J. Hoban and has published in prestigious journals such as PLoS ONE, Applied and Environmental Microbiology and Scientific Reports.

In The Last Decade

Laura Mataseje

44 papers receiving 958 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Laura Mataseje	654	347	265	171	169	44	972
Kayo Shimada	675 1.0×	343 1.0×	286 1.1×	137 0.8×	139 0.8×	35	866
Mari Matsui	612 0.9×	344 1.0×	253 1.0×	149 0.9×	71 0.4×	53	910
Linda Hadjadj	761 1.2×	273 0.8×	184 0.7×	349 2.0×	103 0.6×	52	940
Akela Ghazawi	897 1.4×	476 1.4×	312 1.2×	327 1.9×	83 0.5×	59	1.2k
Suzanne Bialek-Davenet	737 1.1×	341 1.0×	214 0.8×	115 0.7×	114 0.7×	8	840
José María González‐Alba	672 1.0×	303 0.9×	170 0.6×	276 1.6×	69 0.4×	24	948
Lingbin Shu	1.2k 1.8×	461 1.3×	307 1.2×	236 1.4×	236 1.4×	18	1.3k
Alejandro Petroni	763 1.2×	460 1.3×	248 0.9×	224 1.3×	54 0.3×	37	1.1k
Jean-Didier Cavallo	635 1.0×	316 0.9×	533 2.0×	127 0.7×	67 0.4×	20	1.1k
Badrul Hasan	551 0.8×	287 0.8×	128 0.5×	272 1.6×	68 0.4×	35	835

Countries citing papers authored by Laura Mataseje

Since Specialization

Citations

This map shows the geographic impact of Laura Mataseje's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Mataseje with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Mataseje more than expected).

Fields of papers citing papers by Laura Mataseje

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Mataseje. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Mataseje. The network helps show where Laura Mataseje may publish in the future.

Co-authorship network of co-authors of Laura Mataseje

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Mataseje. A scholar is included among the top collaborators of Laura Mataseje based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Mataseje. Laura Mataseje is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhanel, George G., Melanie Baxter, Philippe Lagacé‐Wiens, et al.. (2025). Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007–23). Journal of Antimicrobial Chemotherapy. 80(Supplement_2). ii15–ii26. 1 indexed citations

Lagacé‐Wiens, Philippe, Laura Mataseje, Melissa McCracken, et al.. (2025). Increasing rates of ESBL-producing Escherichia coli and Klebsiella pneumoniae in Canadian Hospitals: 17 years of the CANWARD study, 2007–23. Journal of Antimicrobial Chemotherapy. 80(Supplement_2). ii45–ii53. 1 indexed citations

Mataseje, Laura, Nicole Lerminiaux, Philippe Lagacé‐Wiens, et al.. (2025). Characterization of ertapenem-resistant Enterobacterales in Canadian hospitals: 17 years of the CANWARD study (2007–23). Journal of Antimicrobial Chemotherapy. 80(Supplement_2). ii54–ii61. 1 indexed citations

Lerminiaux, Nicole, et al.. (2024). Do we still need Illumina sequencing data? Evaluating Oxford Nanopore Technologies R10.4.1 flow cells and the Rapid v14 library prep kit for Gram negative bacteria whole genome assemblies. Canadian Journal of Microbiology. 70(5). 178–189. 25 indexed citations

Barker, Kevin R., et al.. (2024). When the Trojan horse is unable to reach inside the city: investigation of the mechanism of resistance behind the first reported cefiderocol-resistant E. coli in Canada. Microbiology Spectrum. 12(5). e0322323–e0322323. 3 indexed citations

Mataseje, Laura, et al.. (2024). Emergence of a novel FRI-type carbapenemase; blaFRI-12 in Enterobacter asburiae located on an IncR plasmid. European Journal of Clinical Microbiology & Infectious Diseases. 43(10). 2047–2051. 1 indexed citations

Mataseje, Laura, Johann Pitout, Matthew A. Croxen, M. R. Mulvey, & Tanis C. Dingle. (2023). Three separate acquisitions of blaNDM-1 in three different bacterial species from a single patient. European Journal of Clinical Microbiology & Infectious Diseases. 42(10). 1275–1280. 2 indexed citations

Mataseje, Laura, Florence Doualla‐Bell, David A. Boyd, et al.. (2023). Genetic and Phenotypic Characterization of the First Canadian Case of Ambler Class A Carbapenemase FRI-8. Microbial Drug Resistance. 29(2). 47–50. 3 indexed citations

Mataseje, Laura, et al.. (2022). Klebsiella pneumoniae ST147: and then there were three carbapenemases. European Journal of Clinical Microbiology & Infectious Diseases. 41(12). 1467–1472. 11 indexed citations

10.

Golden, Alyssa, Melanie Baxter, James A. Karlowsky, et al.. (2021). Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007–19. JAC-Antimicrobial Resistance. 4(1). dlab197–dlab197. 18 indexed citations

11.

Doualla‐Bell, Florence, David A. Boyd, Patrice Savard, et al.. (2021). Analysis of an IncR Plasmid Carrying bla _NDM-1 Linked to an Azithromycin Resistance Region in Enterobacter hormaechei Involved in an Outbreak in Quebec. Microbiology Spectrum. 9(3). e0199821–e0199821. 5 indexed citations

12.

Mataseje, Laura, et al.. (2018). Investigation of a Carbapenemase-producing Acinetobacter baumannii outbreak using whole genome sequencing versus a standard epidemiologic investigation. Antimicrobial Resistance and Infection Control. 7(1). 140–140. 14 indexed citations

13.

Boyd, David A., Geoffrey Taylor, Jeff Fuller, et al.. (2014). Complete Sequence of Four Multidrug-Resistant MOB _Q1 Plasmids Harboring bla _GES-5 Isolated from Escherichia coli and Serratia marcescens Persisting in a Hospital in Canada. Microbial Drug Resistance. 21(3). 253–260. 14 indexed citations

14.

Mataseje, Laura, David A. Boyd, J Delport, et al.. (2014). Serratia marcescens harbouring SME-type class A carbapenemases in Canada and the presence of blaSME on a novel genomic island, SmarGI1-1. Journal of Antimicrobial Chemotherapy. 69(7). 1825–1829. 27 indexed citations

15.

Christian, Nicole, Barbara Willey, Laura Mataseje, et al.. (2012). The detection of the NDM-1 and other carbapenemase genes in multidrug resistant Gram negative bacilli (MDRGNB) in a Jamaican hospital. International Journal of Infectious Diseases. 16. e434–e435. 2 indexed citations

16.

Mataseje, Laura, Elizabeth Bryce, D. Roscoe, et al.. (2012). Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP). Journal of Antimicrobial Chemotherapy. 67(6). 1359–1367. 74 indexed citations

17.

McCracken, Melissa, Laura Mataseje, Vivian G. Loo, et al.. (2011). Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007–2009 study. Diagnostic Microbiology and Infectious Disease. 69(3). 335–341. 18 indexed citations

18.

Mataseje, Laura, David A. Boyd, Barbara Willey, et al.. (2011). Plasmid comparison and molecular analysis of Klebsiella pneumoniae harbouring blaKPC from New York City and Toronto. Journal of Antimicrobial Chemotherapy. 66(6). 1273–1277. 39 indexed citations

19.

Baudry, Patricia J., Laura Mataseje, George G. Zhanel, Daryl J. Hoban, & Michael R. Mulvey. (2009). Characterization of plasmids encoding CMY-2 AmpC β-lactamases from Escherichia coli in Canadian intensive care units. Diagnostic Microbiology and Infectious Disease. 65(4). 379–383. 44 indexed citations

20.

Mataseje, Laura, Jerry Xiao, Sara E. Kost, et al.. (2009). Characterization of Canadian cefoxitin-resistant non-typhoidal Salmonella isolates, 2005-06. Journal of Antimicrobial Chemotherapy. 64(4). 723–730. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact